Friday, June 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 166 of 1,261

  1. US 11779657

    Compositions and methods for mitochondrial genome editing

    The Regents of the University of California · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  2. US 11780805

    Carbamoyl phenylalaninol compounds and uses thereof

    AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  3. US 11780852

    Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

    Theravance Biopharma R&D IP, LLC · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  4. US 11780879

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    The Board of Regents of the University of Texas System · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  5. US 11781143

    Modulators of PNPLA3 expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  6. US 11778995

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  7. US 11780885

    Zika viral antigen constructs

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  8. US 11779660

    Viral vectors for cancer therapy

    Krystal Biotech, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  9. US 11781110

    Induction of corneal endothelial cells

    The Regents of the University of California · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  10. US 11780839

    Compounds for treating Huntington's disease

    PTC THERAPEUTICS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  11. US 11780845

    FGFR inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  12. US 11781101

    3D-printed models of biological microenvironments

    Regents of the University of Minnesota · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  13. US 2023312523

    NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Granted Oct 5, 2023 · Expires Sep 30, 2043

    granted

  14. US 11771776

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  15. US 11773085

    Methods and compounds for treating disorders

    FOGHORN THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  16. US 11773138

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  17. US 11771879

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  18. US 11773157

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  19. US 11773076

    Crystalline forms of a somatostatin modulator

    CRINETICS PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  20. US 11773103

    IRAK4 degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  21. US 11771723

    Bifidobacterium longum NCIMB 41676

    PrecisionBiotics Group Limited · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  22. US 11773156

    Anti-hemagglutinin antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  23. US 11771745

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  24. US 11773185

    Anti-BACE1 antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.